WSGR logoWSGR logo
Haoqian Chen
Registered Foreign Lawyer
Corporate
Hong Kong

D852-39724981

Download vCard
Open PDF

Haoqian Chen is a registered foreign lawyer in the Hong Kong office of Wilson Sonsini Goodrich & Rosati, where he focuses on public mergers and acquisitions, corporate finance, initial public offerings, and corporate governance.

Haoqian was previously an associate in the Beijing office of Wilson Sonsini. Prior to joining the firm, he was an associate at a leading UK law firm.

Haoqian is native in Mandarin and fluent in English.

Experience

Haoqian Chen is a registered foreign lawyer in the Hong Kong office of Wilson Sonsini Goodrich & Rosati, where he focuses on public mergers and acquisitions, corporate finance, initial public offerings, and corporate governance.

Haoqian was previously an associate in the Beijing office of Wilson Sonsini. Prior to joining the firm, he was an associate at a leading UK law firm.

Haoqian is native in Mandarin and fluent in English.

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises Underwriters on Black Sesame IPO and SEHK Listing, the First-Filed Chapter 18C Listing in Hong Kong
On August 8, 2024, Black Sesame International Holding Limited (Black Sesame) successfully listed on the Main Board of the Stock Exchange of Hong Kong, raising gross proceeds of approximately HK$1,036 million (US$132.6 million) from its IPO (the Listing), with market capitalization of approximately US$2 billion. Black Sesame is the first-filed Specialist Technology Company that was successfully listed under Chapter 18C of the Hong Kong Listing Rules, a new regime introduced by the SEHK in March 2023 primarily for pre-revenue technology companies. Black Sesame’s IPO is also one of the largest offerings in the Hong Kong market in 2024. Wilson Sonsini Goodrich & Rosati acted as the Hong Kong and U.S. counsel in the Listing to the underwriting syndicate led by the joint sponsors China International Capital Corporation Hong Kong Securities Limited and Huatai Financial Holdings (Hong Kong) Limited.
Learn More
Alerts
Wilson Sonsini Advises PW Medtech on Spin-Off of Sichuan Rekind Medtec
On July 2, 2024, PW Medtech Group Limited (PW Medtech) announced that it will spin off its subsidiary, Sichuan Rekind Medtec, Inc. (Sichuan Rekind Medtec), by way of a separate quotation on the National Equities Exchange and Quotations System (NEEQS Quotation) and a subsequent listing on the Beijing Stock Exchange, subject to the then-market conditions and its strategic development needs (together with the NEEQS Quotation, the “Proposed Spin-Off”). PW Medtech has obtained approval from The Stock Exchange of Hong Kong Limited, confirming that it may proceed with the Proposed Spin-Off under Practice Note 15 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. On June 26, 2024, Sichuan Rekind Medtec submitted an application for the NEEQS Quotation. Wilson Sonsini Goodrich & Rosati acted as the Hong Kong counsel to PW Medtech in connection with the Proposed Spin-Off.
Learn More
View All
WSGR logo
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.